University of Minnesota. Driven to Discover.
In global developments, European officials warn of a growing gap in vaccine coverage, and the WHO certifies measles and rubella elimination in Bahrain, Oman, and Iran.
The WHO is stepping up its response in Europe, as cases surge in Tunisa and researchers plot at-risk US sites.
Cases have now topped 1,300 and include 843 deaths, with no signs of slowing.
As has been the case, California, Florida, New York, and Texas reported half of all TB cases.
Though incidence is down, treatment success for resistant strains is low.
Among the findings are very high to extremely high levels of resistance to ciprofloxacin in Campylobacter isolates from people.
The proportion of broad-spectrum antibiotics used in hospitals ranged from 16% to 62%.
The researchers estimate that 670,000 infections are caused by select antibiotic-resistant bacteria in a year.
High and rising prevalence of CRE in some nations could pose a healthcare threat across Europe.
The cases indicate a need for action to preserve the last remaining effective treatment.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.